mynth
← DATABASE
02/2021

IVC EVIDENSIA acquired by SILVER LAKE & NESTLE

UNITED KINGDOM Health Providers / Outpatient Care / Vet Clinics EV 3b - 100b GBP

Context

Silver Lake and Nestle led a EUR3.5 billion capital investment in IVC Evidensia, significantly increasing the group's valuation. The deal allowed EQT VII to partially exit its position, while EQT IX reinvested to remain the majority shareholder. The transaction served as a private alternative to a previously considered IPO. Silver Lake's entry is designed to accelerate the group's digital transformation, while Nestle's increased stake facilitates deep collaboration between veterinary clinical care and nutritional science. This "pet-tech" and "pet-health" convergence aims to create a data-driven ecosystem for pet owners, enhancing diagnostic accuracy and tailored health solutions across IVC's pan-European network.

IVC EVIDENSIA, which reported an EBITDA margin of LOGIN in 2021, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Healthcare & Pharma sector (14.4x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

IVC Evidensia is Europe s leading veterinary care provider and one of the world s largest animal healthcare networks, operating across more than 20 countries. The group functions through a decentralized operational model that preserves local clinical independence while providing the benefits of a large-scale international support infrastructure. Its network encompasses primary care practices, 24/7 emergency clinics, and advanced specialist referral centers. Beyond clinical medicine, the group integrates a holistic ecosystem of services, including veterinary telemedicine, specialized nutrition, and pharmaceutical distribution.

Ent. Value

LOGIN

Equity Value

LOGIN

Multiples

EV / Revenue

LOGIN

EV / EBITDA

LOGIN

EV / EBIT

LOGIN

Historical Financials (GBP)

Year
Rev
EBITDA
EBIT
2021
LOGIN
LOGIN
LOGIN
2020
LOGIN
LOGIN
LOGIN

Other operations with IVC EVIDENSIA

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
DateAcquirerTargetCountrySectorDeal Context
10/2021IVC EVIDENSIAVETONEFRANCEHealth Providers

IVC Evidensia acquired VetOne in a preemptive move to consolidate its leadership in the French market. The deal successfully bypassed a planned auction process due to a high-premium offer. The transaction provided an exit for VetOne's shareholders, including the founder, practicing veterinarians, and various private investors. The strategic rationale was to integrate VetOne's 51 clinics with IVC's existing French footprint, creating a dominant national player. The investment thesis is supported by low market consolidation in France and significant upside in ancillary services such as pet insurance, specialized medication, and premium pet food sales.

REFERENCES

Valuation range: EV 3b - 100b GBP

Revenue range: 1b - 3b GBP

EBITDA range: 450M - 900M GBP

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of IVC EVIDENSIA by SILVER LAKE / NESTLE are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Acquirer: silver lake